Nocion Therapeutics

About:

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Website: https://www.nociontx.com/

Top Investors: Mission BioCapital, F-Prime Capital, OUP (Osage University Partners), Arkin Holdings, Mass General Brigham Ventures

Description:

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)nociontx.com

Founders:

Bruce Bean, Bruce Levy, Clifford J Woolf

Number of Employees:

11-50

Last Funding Date:

2024-03-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai